Moreover, JNK appeared to sustain growth of melanoma cells exposed to TMZ, because upon pharmacological JNK-inhibition, a synergistic effect could be obtained, similarly to what observed with SAHA, further corroborating that JNK pathway impairment is implicated in inhibition of melanoma cell growth. The gene discussed is MAPK8; the disease is melanoma.